Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma

BACKGROUND: Histone deacetylase inhibitor romidepsin has demonstrated durable clinical responses and tolerability in patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma (PTCL, CTCL). Selection of novel drug therapies for patients with relapsed/refractory aggressive lymphoma re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Foss, Francine, Coiffier, Bertrand, Horwitz, Steven, Pro, Barbara, Prince, H Miles, Sokol, Lubomir, Greenwood, Matthew, Lerner, Adam, Caballero, Dolores, Baran, Eugeniusz, Kim, Ellen, Nichols, Jean, Balser, Barbara, Wolfson, Julie, Whittaker, Sean
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4181623/
https://ncbi.nlm.nih.gov/pubmed/25279222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2050-7771-2-16
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados